Matthew D. Shair Ph.D.
Net Worth
Last updated:
What is Matthew D. Shair Ph.D. net worth?
The estimated net worth of Prof. Matthew D. Shair Ph.D. is at least $56,432,257 as of 25 Nov 2024. He owns shares worth $16,689,150 as insider, has earned $39,143,107 from insider trading and has received compensation worth at least $600,000 in Nuvalent, Inc..
What is the salary of Matthew D. Shair Ph.D.?
Prof. Matthew D. Shair Ph.D. salary is $200,000 per year as Founder, Head of Scientific Advisory Board & Director in Nuvalent, Inc..
How old is Matthew D. Shair Ph.D.?
Prof. Matthew D. Shair Ph.D. is 57 years old, born in 1968.
What stocks does Matthew D. Shair Ph.D. currently own?
As insider, Prof. Matthew D. Shair Ph.D. owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Nuvalent, Inc. (NUVL) | Founder, Head of Scientific Advisory Board & Director | 222,522 | $75 | $16,689,150 |
What does Nuvalent, Inc. do?
Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferring resistance to approved and investigational ROS1 inhibitors, which is under Phase I development; and NVL-655, a brain-penetrant ALK-selective inhibitor, to address the clinical challenges of emergent treatment resistance, central nervous system-related adverse events, and brain metastases that might limit the use of first-, second-, and third-generation ALK inhibitors that is under Phase I/II clinical trial. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Matthew D. Shair Ph.D. insider trading
Nuvalent, Inc.
Prof. Matthew D. Shair Ph.D. has made 66 insider trades between 2022-2024, according to the Form 4 filled with the SEC. Most recently he sold 30 units of NUVL stock worth $2,922 on 25 Nov 2024.
The largest trade he's ever made was exercising 81,531 units of NUVL stock on 24 Oct 2023. As of 25 Nov 2024 he still owns at least 222,522 units of NUVL stock.
Nuvalent key executives
Nuvalent, Inc. executives and other stock owners filed with the SEC:
- Dr. James R. Porter Ph.D. (50) Chief Executive Officer, Pres & Director
- Prof. Matthew D. Shair Ph.D. (57) Founder, Head of Scientific Advisory Board & Director